Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded
- Contract number
- SPE2DB25FGPQM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,986
Award facts
- Contract value 100% obligated
- $17,985.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,985.92 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods, with a completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The award supports the federal government's medical supply chain requirements, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies comprehensive medical products and pharmaceutical commodities to military and veteran healthcare systems.
This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a broad range of brand-name and generic drugs, specialty medications, vaccines, medical devices, and test kits across multiple therapeutic domains to support military healthcare programs worldwide. The contract vehicle supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FGPQM?
SPE2DB25FGPQM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FGPQM worth?
The government has obligated $17,986 on SPE2DB25FGPQM.
Is contract SPE2DB25FGPQM an order under another contract?
Yes. SPE2DB25FGPQM is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPQM competed?
The extent of competition for SPE2DB25FGPQM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award